Securing the medication can be a hurdle for many. Currently, it's is restricted and requires a prescription from a doctor . Obtaining retatrutide typically involves participating in a investigative program, though potential expanded release through traditional pharmaceutical channels is being explored – though a date for this remains uncertain .